1. A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma. Issue 3 (21st October 2020) Authors: Gilbert, Mark R; Yuan, Ying; Wu, Jimin; Mendoza, Tito; Vera, Elizabeth; Omuro, Antonio; Lieberman, Frank; Robins, H Ian; Gerstner, Elizabeth R; Wu, Jing; Wen, Patrick Y; Mikkelsen, Tom; Aldape, Kenneth; Armstrong, Terri S Journal: Neuro-oncology Issue: Volume 23:Issue 3(2021) Page Start: 468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation. Issue 6 (19th December 2015) Authors: Hatzoglou, Vaios; Yang, T. Jonathan; Omuro, Antonio; Gavrilovic, Igor; Ulaner, Gary; Rubel, Jennifer; Schneider, Taylor; Woo, Kaitlin M.; Zhang, Zhigang; Peck, Kyung K.; Beal, Kathryn; Young, Robert J. Journal: Neuro-oncology Issue: Volume 18:Issue 6(2016:Jun.) Page Start: 873 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Shortage of Neurologists – We Must Act Now: A Report From the AAN 2019 Transforming Leaders Program. (15th June 2021) Authors: Majersik, Jennifer J.; Ahmed, Aiesha; Chen, I-Hweii A.; Shill, Holly; Hanes, Gregory P.; Pelak, Victoria S.; Hopp, Jennifer L.; Omuro, Antonio; Kluger, Benzi; Leslie-Mazwi, Thabele Journal: Neurology Issue: Volume 96:Number 24(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ATIM-47. NIVOLUMAB VS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: EXPLORATORY ANALYSIS OF MGMT METHYLATION STATUS AND BASELINE CORTICOSTEROID USE. (11th November 2019) Authors: Weller, Michael; Reardon, David; Brandes, Alba; Sampson, John; Mulholland, Paul; Wick, Antje; Baehring, Joachim; Ahluwalia, Manmeet; Roth, Patrick; Bähr, Oliver; Phuphanich, Surasak; Sepulveda, Juan; de Souza, Paul; Sahebjam, Solmaz; Potter, Von; Tatsuoka, Kay; Taitt, Corina; Zwirtes, Ricardo; Om... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bevacizumab for acute neurologic deterioration in patients with glioblastoma. (September 2013) Authors: Kaley, Thomas; Nolan, Craig; Carver, Alan; Omuro, Antonio Journal: CNS oncology Issue: Volume 2:Number 5(2013) Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bilateral radiation therapy followed by methotrexate‐based chemotherapy for primary vitreoretinal lymphoma. Issue 4 (4th February 2019) Authors: de la Fuente, Macarena I.; Alderuccio, Juan Pablo; Reis, Isildinha M.; Omuro, Antonio; Markoe, Arnold; Echegaray, Jose J.; Davis, Janet L.; Harbour, J. William; Lossos, Izidore S. Journal: American journal of hematology Issue: Volume 94:Issue 4(2019:Apr.) Page Start: 455 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients. Issue 3 (13th August 2014) Authors: Vera-Bolanos, Elizabeth; Aldape, Kenneth; Yuan, Ying; Wu, Jimin; Wani, Khalida; Necesito-Reyes, Mary Jo; Colman, Howard; Dhall, Girish; Lieberman, Frank S.; Metellus, Philippe; Mikkelsen, Tom; Omuro, Antonio; Partap, Sonia; Prados, Michael; Robins, H. Ian; Soffietti, Riccardo; Wu, Jing; Gilbert, ... Journal: Neuro-oncology Issue: Volume 17:Issue 3(2015:Mar.) Page Start: 440 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Complications associated with immunotherapy for brain metastases. Issue 6 (December 2019) Authors: Tran, Thuy T.; Jilaveanu, Lucia B.; Omuro, Antonio; Chiang, Veronica L.; Huttner, Anita; Kluger, Harriet M. Journal: Current opinion in neurology Issue: Volume 32:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CTIM-25. A RANDOMIZED PHASE 3 STUDY OF NIVOLUMAB OR PLACEBO COMBINED WITH RADIOTHERAPY PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA WITH METHYLATED MGMT PROMOTER: CHECKMATE 548. (12th November 2021) Authors: Weller, Michael; Lim, Michael; Idbaih, Ahmed; Steinbach, Joachim; Finocchiaro, Gaetano; Raval, Raju; Ashby, Lynn; Ansstas, George; Baehring, Joachim; Taylor, Jennie; Honnorat, Jerome; Petrecca, Kevin; de Vos, Filip; Wick, Antje; Sumrall, Ashley; Roberts, Mustimbo; Slepetis, Ruta; Warad, Deepti; L... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. CTNI-18. PHASE I AND PRELIMINARY PHASE 0 RESULTS OF ABTC 1801: A MULTI-ARM CLINICAL TRIAL OF THE PARP INHIBITOR PAMIPARIB (BGB290) WITH VERY LOW DOSE METRONOMIC TEMOZOLOMIDE IN RECURRENT IDH MUTANT GLIOMAS. (12th November 2021) Authors: Schiff, David; Bindra, Ranjit; Li, Jing; Ye, Xiaobu; Ellingson, Benjamin; Walbert, Tobias; Campian, Jian; Nabors, L Burt; Lieberman, Frank; Ozer, Byran; Desai, Arati; Omuro, Antonio; Wen, Patrick; Desideri, Serena; Fisher, Joy; Grossman, Stuart Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗